secwatch.observer — SEC 8-K summary
======================================

Issuer:     InMed Pharmaceuticals Inc. (INM)
CIK:        0001728328
Form:       8-K
Filed at:   2026-05-19T10:03:08+00:00
Accession:  0001062993-26-002787
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 1.01, 3.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InMed amends Armistice option exercise price from $16.60 to $0.80 per share
---------------------------------------------------------------------------

- Up to 278,761 common shares subject to options; exercise price reduced to $0.80 from $16.60.
- Options originally issued October 26, 2023; amendment entered May 18, 2026.
- Dramatic price reduction may increase dilution risk for existing shareholders if exercised.
- Press release issued May 19, 2026 confirms amendment; no assurance options will be exercised.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1728328/000106299326002787/0001062993-26-002787-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1728328/000106299326002787/form8k.htm
  HTML page:      https://secwatch.observer/filing/0001062993-26-002787

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer